Peking Union Medical College
88
14
21
21
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 88 trials
100.0%
+13.5% vs industry average
15%
13 trials in Phase 3/4
0%
0 of 21 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (88)
AI-Powered Scoliosis Auto-Analysis System Multicenter Development and Validations
Role: collaborator
Efficacy and Safety of IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2)
Role: collaborator
Impact of Multi-component Interventions on Populations With Mental Health Symptoms and High-risk COPD
Role: lead
Impact of Multi-Component Intervention on Suspected Asthma Population
Role: lead
Impact of Multi-Component Interventions on High Risk COPD Population
Role: lead
Impact of Multi-Component Interventions on High-Risk COPD Smokers
Role: lead
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
Role: lead
Retrospective Follow-up Study on Lower Eyelid Melanin and Wrinkles After Blepharoplasty for Lower Eyelid Bags
Role: lead
Development and Prospective Validation of an AI Model for Prognosis in ITP Patients Undergoing Coronary Revascularization
Role: collaborator
Effect of Indoor Air Quality Improvement on Health in Patients With Interstitial Lung Disease
Role: lead
Nutrition Support on Outcomes and Cost-effectiveness for Patients at Risk
Role: lead
Nutritional Support on Outcomes and Cost-effectiveness for Patients at Risk
Role: lead
AI-Driven Dynamic Prediction of Non-Target Lesion Progression After PCI: A Chinese Multicenter Cohort Study
Role: collaborator
Construction and Preliminary Application of Evidence-Based Nursing Protocol for Oral Mucositis Related to Tumor Therapy
Role: lead
Two- and Three-Dimensional Quantification of Facial Symmetry After Fat Grafting and Free Flap Reconstruction in Hemifacial Atrophy
Role: lead
Furmonertinib in EGFR-Mutant NSCLC With Brain Metastases (iFORCE)
Role: lead
The Role of Auricular Point Diagnosis and Treatment in ERAS During TKA
Role: lead
Aneurysmal Subarachnoid Hemorrhage Multi-Omics Research Program
Role: collaborator
Comparison of the Clinical Efficacy and Safety of Topical and Subcutaneous Injection of Secukinumab in HS
Role: lead
Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC
Role: lead